You can use your existing Medical Independent, MediLearning or PharmacistCPD account to log in.


Medicalindependent.ie is Ireland's only investigative medical news website for doctors, healthcare professionals and anyone with an interest in health issues.

Established in 2010, along with its sister publication The Medical Independent, our stated aim is to investigate and analyse the major issues affecting healthcare and the medical profession in Ireland. The Medical Independent has won a number of awards for its investigative journalism, and its stories are frequently picked up by national digital, broadcast and print media. The Medical Independent is published by GreenCross Publishing.

Address: Top Floor, 111 Rathmines Road Lr, Dublin 6

Tel: 353 (01) 441 0024

GreenCross Publishing is owned by Graham Cooke.


The benefits of registering: only registered users:
  • receive the ecCopy two days prior to the printed edition.
  • have automatic access to our free CPD sites.
  • can partake in our online MCQs.
  • can enter our online sports quiz.

Sign up now for ease of access to The Medical Independent, Ireland’s most frequently published medical newspaper, delivering award-winning news and investigative reporting.

Download the new Mindo app for both IOS & Android.

  • Get notified when a story goes live
  • Access Premium Content
  • Read Offline
 

You are reading 1 of 2 free-access articles allowed for 30 days

Metformin could play a part in future RA treatment

By Mindo - 07th Oct 2015 | 4 views

Scientist Dr Lorna Gallagher, Trinity College Dublin, spoke about the role of metformin on synovial fibroblasts and the findings of a research project she is involved in, during her oral presentation at the ISR Autumn Meeting.

She reported that insulin resistance is seen in some patients with RA, and it has now been established that there is a clear link between metabolism in the cells and inflammation. Metformin has the potential to reverse inflammation process in RA synovial fibroblasts, the new research has shown.

Speaking to the Medical Independent, Dr Gallagher said the research she is carrying out ultimately aims to enhance the success of current treatments for RA. “A lot of them have side-effects; the nausea with methotrexate is a big issue, so we are try to bring in an alternative ‘helper’ so they can reduce the dosage of methotrexate by adding in a very widely-used drug, ie metformin, and thus help improve the quality of life for RA patients and maximise their results.

“While this is currently just a theory, we are seeing some very positive results in metformin decreasing the inflammation from the fibroblast cells in RA samples. Metformin has been shown to decrease cardiovascular disease and pancreatic risks, so there is definitely a link there and the metabolism is involved in everything, which is a very hot topic at the moment,” Dr Gallagher said.

Dr Gallagher won the 2014 ISR Young Investigator Award for her work on the potential role of metformin in RA.

Leave a Reply

Latest Issue
The Medical Independent – 24 June 2021

You need to be logged in to access this content. Please login or sign up using the links below.

Most Read